Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

649
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
649

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Digital Exposure and Skin Health in Children and Adolescents: A State-of-the-Art Review.

Cureus·2026
Same author

Application of <i>Pseudomonas mosselii</i> PR5 Enables Fertilizer Reduction in Rice While Maintaining Yield, Grain Quality, and Soil Nutrient Dynamics.

Plant-environment interactions (Hoboken, N.J.)·2026
Same author

Enhancing rice productivity, grain quality and soil fertility through Pseudomonas mosselii biopriming.

Scientific reports·2026
Same author

Engineered hepatic cells with stable expansion and heat-inducible liver function.

Scientific reports·2026
Same author

A cohort study on poisons, clinical insights, management of poisoning, and predictors of mortality in Pakistan.

Scientific reports·2026
Same author

Cre-loaded integrase-defective lentiviral vectors for targeted cassette exchange in CHO cells.

Journal of bioscience and bioengineering·2026

相关实验视频

Updated: Jun 12, 2025

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

13.7K

生物工程黑巴林:生产技术的进步.

Razia Sultana1, Masamichi Kamihira2

  • 1Department of Chemical Engineering, Faculty of Engineering, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan; Department of Biotechnology and Genetic Engineering, Faculty of Science, Noakhali Science and Technology University, Noakhali 3814, Bangladesh.

Biotechnology advances
|September 26, 2024
PubMed
概括

生物工程制造的肝素为动物来源提供了更安全,更一致的替代品. 代谢工程和合成生物学方面的进步正在为改善这种重要抗凝剂的生产铺平道路.

关键词:
抗凝剂药物是抗凝剂药物.生物工程制造的肝素是生物工程制造的肝素.葡萄糖氨基甘油可以.代谢工程是代谢工程.合成生物学 合成生物学

更多相关视频

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery
12:27

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery

Published on: August 22, 2016

7.6K
Surface Engineering of Pancreatic Islets with a Heparinized StarPEG Nanocoating
05:35

Surface Engineering of Pancreatic Islets with a Heparinized StarPEG Nanocoating

Published on: June 23, 2018

7.3K

相关实验视频

Last Updated: Jun 12, 2025

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

13.7K
Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery
12:27

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery

Published on: August 22, 2016

7.6K
Surface Engineering of Pancreatic Islets with a Heparinized StarPEG Nanocoating
05:35

Surface Engineering of Pancreatic Islets with a Heparinized StarPEG Nanocoating

Published on: June 23, 2018

7.3K

科学领域:

  • 生物化学 生化学
  • 合成生物学 合成生物学
  • 生物技术是生物技术.

背景情况:

  • 肝素是从动物组织中提取的关键抗凝剂,在结构变异性和改方面面临挑战.
  • 它的治疗潜力延伸到炎症,癌症和COVID-19等传染病.
  • 目前以动物为基础的采购限制了有效性和安全性.

研究的目的:

  • 审查生物工程肝素生产的最新进展.
  • 探索 prokaryotic 和 eukaryotic 系统中的代谢工程策略.
  • 讨论中国仓鼠卵巢细胞用于氨酸合成的潜力.

主要方法:

  • 检查 prokaryotic 系统中的代谢工程策略.
  • 分析生物工程肝素开发的进展.
  • 在真核系统中探索生产增强方法,包括重组中国子卵巢细胞.

主要成果:

  • 代谢工程的进步用于各种系统中的肝素生产.
  • 开发生物工程制造的肝素,对分子量和硫化进行更好的控制.
  • 识别基于重组细胞的合成中的挑战和未来前景.

结论:

  • 生物工程制造的肝素是动物来源的有希望的替代品.
  • 代谢工程和合成生物学提供了克服当前生产限制的途径.
  • 再组合的中国仓鼠卵巢细胞显示了未来肝素合成的潜力,需要进一步研究.